Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:59 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500488 | NSE: ABBOTINDIA

Abbott India Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹20,253.11Overvalued by 23.54%vs CMP ₹26,490.00

P/E (36.9) × ROE (35.7%) × BV (₹1,888.00) × DY (1.79%)

₹10,849.24Overvalued by 59.04%vs CMP ₹26,490.00
MoS: -144.2% (Negative)Confidence: 70/100 (High)Models: All 10: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹23,047.3320%Over (-13%)
Graham NumberEarnings₹5,519.9314%Over (-79.2%)
Earnings PowerEarnings₹4,598.6912%Over (-82.6%)
DCFCash Flow₹13,772.0112%Over (-48%)
Net Asset ValueAssets₹1,887.546%Over (-92.9%)
EV/EBITDAEnterprise₹9,892.758%Over (-62.7%)
Dividend DiscountDividends₹15,125.008%Over (-42.9%)
Earnings YieldEarnings₹7,172.706%Over (-72.9%)
ROCE CapitalReturns₹5,524.928%Over (-79.1%)
Revenue MultipleRevenue₹4,524.025%Over (-82.9%)
Consensus (10 models)₹10,849.24100%Overvalued
Key Drivers: Wide model spread (₹1,888–₹23,047) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 13.8%

*Investments are subject to market risks

Investment Snapshot

76
Abbott India Ltd scores 76/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health88/100 · Strong
ROCE 46.2% ExcellentROE 35.7% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.03% (6mo) Slight increasePromoter holding at 75.0% Stable
Earnings Quality65/100 · Strong
OPM expanding (23% → 26%) Improving
Quarterly Momentum68/100 · Strong
Revenue (4Q): +9% YoY GrowingProfit (4Q): +14% YoY Positive
Industry Rank90/100 · Strong
P/E 36.9 vs industry 53.8 Cheaper than peersROCE 46.2% vs industry 16.4% Above peersROE 35.7% vs industry 15.2% Above peers3Y sales CAGR: 9% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Abbott India Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
40/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 36.9 vs Ind 53.8 | ROCE 46.2% | ROE 35.7% | CFO/NP N/A
Balance Sheet Stress
0/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.00x | IntCov 0.0x | Current 3.41x | Borrow/Reserve 0.05x
Cash Flow Reliability
14/100
Weak
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹1,414 Cr | CFO/NP N/A
Ownership Accumulation
0
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII +0.03 pp | DII -0.11 pp | Prom 0.00 pp
Business Momentum
-21
Early weakness
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales -1.9% | Q NP -9.4% | Q OPM -2.0 pp
Derived FieldValueHow it is derived
Valuation Gap %-59.0%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.05xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change+0.03 ppLatest FII% minus previous FII%
DII Change-0.11 ppLatest DII% minus previous DII%
Promoter Change0.00 ppLatest promoter% minus previous promoter%
Shareholder Count Change+4,602Latest shareholder count minus previous count
Quarterly Sales Change-1.9%Latest quarter sales vs previous quarter sales
Quarterly Profit Change-9.4%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change-2.0 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:59 am

Market Cap 56,291 Cr.
Current Price 26,490
Intrinsic Value₹10,849.24
High / Low 37,000/25,350
Stock P/E36.9
Book Value 1,888
Dividend Yield1.79 %
ROCE46.2 %
ROE35.7 %
Face Value 10.0
PEG Ratio2.67

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Abbott India Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Abbott India Ltd 56,291 Cr. 26,490 37,000/25,35036.9 1,8881.79 %46.2 %35.7 % 10.0
Laurus Labs Ltd 56,080 Cr. 1,039 1,141/51770.0 91.10.12 %9.47 %7.75 % 2.00
Biocon Ltd 59,196 Cr. 365 425/29572.1 2000.14 %6.25 %4.76 % 5.00
Glenmark Life Sciences Ltd 59,293 Cr. 2,101 2,298/1,33621.9 3400.12 %19.4 %15.8 % 1.00
Glenmark Pharmaceuticals Ltd 59,293 Cr. 2,101 2,298/1,33621.9 3400.12 %19.4 %15.8 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Abbott India Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,3221,3431,4791,4941,4371,4391,5581,6331,6141,6051,7381,7571,724
Expenses 1,0101,0631,1241,1131,0491,1091,1671,1941,1781,1761,2931,2551,261
Operating Profit 312280355381388330391439436429446502463
OPM % 24%21%24%25%27%23%25%27%27%27%26%29%27%
Other Income 44505656568167607276737070
Interest 4433333224685
Depreciation 18171718181818181818191919
Profit before tax 335308390415422390437479488483493546509
Tax % 26%25%26%25%26%26%25%25%26%24%26%24%26%
Net Profit 247231290313311287328359361367366415376
EPS in Rs 116.16108.91136.59147.27146.35135.09154.36168.76169.78172.73172.18195.43176.93

Last Updated: March 3, 2026, 1:17 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 1:46 pm

MetricMar 2014n n 15mMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2,2762,2892,6142,9033,2983,6794,0934,3104,9195,3495,8496,4096,824
Expenses 2,0091,9772,2502,5052,7743,0743,3363,3883,8324,1434,3964,7144,984
Operating Profit 2673123653985256057579221,0881,2061,4531,6951,840
OPM % 12%14%14%14%16%16%18%21%22%23%25%26%27%
Other Income 494850571171131148177154248275289
Interest 0032429181916121123
Depreciation 22151416161760586670717275
Profit before tax 2953443984366216998039261,0801,2741,6181,8872,031
Tax % 33%34%36%37%35%36%26%25%26%25%26%25%
Net Profit 1982292552774014505936917999491,2011,4141,524
EPS in Rs 93.39107.75120.12130.19188.82211.93279.04325.04375.87446.80565.30665.64717.27
Dividend Payout % 25%29%29%31%29%31%90%85%73%73%73%71%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)11.35%8.63%44.77%12.22%31.78%16.53%15.63%18.77%26.55%17.74%
Change in YoY Net Profit Growth (%)0.00%-2.73%36.14%-32.55%19.56%-15.25%-0.90%3.14%7.78%-8.82%

Abbott India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:9%
3 Years:9%
TTM:11%
Compounded Profit Growth
10 Years:20%
5 Years:19%
3 Years:21%
TTM:17%
Stock Price CAGR
10 Years:20%
5 Years:14%
3 Years:21%
1 Year:8%
Return on Equity
10 Years:30%
5 Years:32%
3 Years:34%
Last Year:36%

Last Updated: September 5, 2025, 2:01 pm

Balance Sheet

Last Updated: December 4, 2025, 2:16 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 21212121212121212121212121
Reserves 7679161,1741,3661,6721,9872,4102,5812,7993,1673,6784,2123,990
Borrowings 00000017515315211383197182
Other Liabilities 3514364216797239329401,0861,2531,2541,4111,4871,501
Total Liabilities 1,1391,3741,6162,0662,4162,9413,5473,8404,2244,5565,1935,9175,694
Fixed Assets 989610811081105270251271237225336314
CWIP 1436212114101823
Investments 0000000000000
Other Assets 1,0401,2741,5051,9502,3332,8353,2753,5893,9524,3154,9585,5635,357
Total Assets 1,1391,3741,6162,0662,4162,9413,5473,8404,2244,5565,1935,9175,694

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1552152493071534996267279488931,2131,012
Cash from Investing Activity + -144-187-77-155-215-257-401-72-396-148-416182
Cash from Financing Activity + -42-58-80-90-102-143-217-582-637-639-745-925
Net Cash Flow -31-309162-16599873-8610752269
Free Cash Flow 1511992262871805046117049048601,165960
CFO/OP 99%106%109%117%68%125%113%104%114%102%111%86%

Free Cash Flow

MonthMar 2014n n 15mMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow267.00312.00365.00398.00525.00605.00582.00769.00-151.00-112.00-82.00-196.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 182120222927282121222022
Inventory Days 101107911071121068311094807092
Days Payable 38545610192116104116122109114110
Cash Conversion Cycle 807454284917814-6-8-243
Working Capital Days 363032216322107-7-8-1497
ROCE %39%40%38%34%41%37%35%35%38%41%46%46%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%
FIIs 0.19%0.19%0.19%0.18%0.18%0.18%0.17%0.17%0.16%0.16%0.16%0.19%
DIIs 8.61%8.77%8.83%8.73%8.91%8.81%9.00%9.01%8.91%9.18%9.11%9.00%
Public 16.20%16.05%16.01%16.09%15.92%16.01%15.86%15.85%15.94%15.67%15.74%15.83%
No. of Shareholders 72,08669,58268,88572,25269,38271,58869,44967,89269,93467,58471,19975,801

Shareholding Pattern Chart

No. of Shareholders

Abbott India Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Large & Midcap Fund 274,878 1.88 729.25155,0002025-10-30 02:04:4977.34%
Axis Midcap Fund 162,848 1.35 432.04165,0402026-01-26 05:00:11-1.33%
Canara Robeco Large and Mid Cap Fund 145,836 1.56 386.9144,8362026-01-25 01:39:510.69%
Nippon India Multi Cap Fund 109,953 0.57 291.71105,9532026-02-23 07:02:123.78%
PGIM India Midcap Fund 74,300 1.81 197.12N/AN/AN/A
Nippon India Pharma Fund 74,187 2.37 196.8268,6772026-01-25 01:59:438.02%
Franklin India Mid Cap Fund 52,304 1.13 138.76N/AN/AN/A
SBI MNC Fund 45,000 2.04 119.3960,0002026-03-23 10:36:52-25%
Canara Robeco Flexi Cap Fund 32,022 0.63 84.9542,3102025-10-30 04:11:08-24.32%
Canara Robeco Large Cap Fund 31,701 0.49 84.1N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 665.62565.28446.78375.86325.04
Diluted EPS (Rs.) 665.62565.28446.78375.86325.04
Cash EPS (Rs.) 699.41598.77479.71406.96352.38
Book Value[Excl.RevalReserv]/Share (Rs.) 1992.071740.651500.491326.961224.55
Book Value[Incl.RevalReserv]/Share (Rs.) 1992.071740.651500.491326.961224.55
Dividend / Share (Rs.) 475.00410.00325.00275.00275.00
Revenue From Operations / Share (Rs.) 3016.072752.432517.052314.952028.24
PBDIT / Share (Rs.) 927.14800.64639.90548.20471.70
PBIT / Share (Rs.) 893.36767.15606.97517.10444.34
PBT / Share (Rs.) 887.98761.29599.44508.11435.74
Net Profit / Share (Rs.) 665.62565.28446.78375.86325.03
PBDIT Margin (%) 30.7429.0825.4223.6823.25
PBIT Margin (%) 29.6127.8724.1122.3321.90
PBT Margin (%) 29.4427.6523.8121.9421.48
Net Profit Margin (%) 22.0620.5317.7516.2316.02
Return on Networth / Equity (%) 33.4132.4729.7728.3226.54
Return on Capital Employeed (%) 42.0942.3338.5036.3733.60
Return On Assets (%) 23.9023.1220.8418.9017.98
Asset Turnover Ratio (%) 1.151.201.221.221.17
Current Ratio (X) 3.392.422.513.203.41
Quick Ratio (X) 2.761.961.972.632.72
Inventory Turnover Ratio (X) 8.549.220.830.700.72
Dividend Payout Ratio (NP) (%) 61.5957.4961.540.000.00
Dividend Payout Ratio (CP) (%) 58.6154.2757.320.000.00
Earning Retention Ratio (%) 38.4142.5138.460.000.00
Cash Earning Retention Ratio (%) 41.3945.7342.680.000.00
Interest Coverage Ratio (X) 172.37136.6685.0460.9954.83
Interest Coverage Ratio (Post Tax) (X) 124.7597.4860.3842.8238.78
Enterprise Value (Cr.) 63674.7155125.7644996.8634862.1129441.84
EV / Net Operating Revenue (X) 9.939.428.417.096.83
EV / EBITDA (X) 32.3232.4033.0929.9329.37
MarketCap / Net Operating Revenue (X) 10.199.798.777.657.39
Retention Ratios (%) 38.4042.5038.450.000.00
Price / BV (X) 15.4315.4814.7213.3412.24
Price / Net Operating Revenue (X) 10.199.798.777.657.39
EarningsYield 0.020.020.020.020.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 6409.15 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals3, Corporate Park, Mumbai Maharashtra 400071Contact not found
Management
NamePosition Held
Mr. Munir ShaikhChairman
Mr. Kartik RajendranManaging Director
Mr. Kaiyomarz MarfatiaNon Executive Director
Mr. Ambati VenuNon Executive Director
Ms. Alison DaviesNon Executive Director
Ms. Anisha MotwaniIndependent Director
Ms. Shalini KamathIndependent Director
Mr. Sudarshan JainIndependent Director

FAQ

What is the intrinsic value of Abbott India Ltd and is it undervalued?

As of 04 April 2026, Abbott India Ltd's intrinsic value is ₹10849.24, which is 59.04% lower than the current market price of ₹26,490.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (35.7 %), book value (₹1,888), dividend yield (1.79 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Abbott India Ltd?

Abbott India Ltd is trading at ₹26,490.00 as of 04 April 2026, with a FY2026-2027 high of ₹37,000 and low of ₹25,350. The stock is currently near its 52-week low. Market cap stands at ₹56,291 Cr..

How does Abbott India Ltd's P/E ratio compare to its industry?

Abbott India Ltd has a P/E ratio of 36.9, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Abbott India Ltd financially healthy?

Key indicators for Abbott India Ltd: ROCE of 46.2 % indicates efficient capital utilization; ROE of 35.7 % shows strong shareholder returns. Dividend yield is 1.79 %.

Is Abbott India Ltd profitable and how is the profit trend?

Abbott India Ltd reported a net profit of ₹1,414 Cr in Mar 2025 on revenue of ₹6,409 Cr. Compared to ₹799 Cr in Mar 2022, the net profit shows an improving trend.

Does Abbott India Ltd pay dividends?

Abbott India Ltd has a dividend yield of 1.79 % at the current price of ₹26,490.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Abbott India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports